Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × abemaciclib × Head & Neck × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 11 Tumor-Agnostic 7 Lymphoid 3 Genitourinary 2 Thoracic 1 Sarcoma 1 Plasma cell 1 Other solid neoplasm 1 Other hematologic neoplasm 1 Myeloid 1 Head & Neck 1 Gynecologic 1 Gastrointestinal 1 Classical hematology 1 CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 3 Head and Neck Neoplasms 3 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Neoplasms, Squamous Cell 1 Neoplasm Metastasis 1

Interventions

pembrolizumab 28 Cetuximab 16 Gemcitabine 14 Cisplatin 12 Nivolumab 11 Paclitaxel 9 Carboplatin 8 Fluorouracil 6 Cyclophosphamide 6 cemiplimab 4 Specimen Handling 4 Magnetic Resonance Spectroscopy 4 Docetaxel 4 Biopsy 4 fludarabine 3 durvalumab 3 aldesleukin 3 Valproic Acid 3 Radiation 3 Interleukin-2 3 Immune Checkpoint Inhibitors 3 130-nm albumin-bound paclitaxel 3 tislelizumab 2 fludarabine phosphate 2 avelumab 2 apatinib 2 Tablets 2 Sirolimus 2 NVP-BKM120 2 Leucovorin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03356223 2023-02-23

ABORL

Centre Leon Berard

Phase 2 Completed

Head and Neck Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡